"PositiveID Corporation announced today that it has sold to a customer the Company's first order of 7,500 eight-millimeter RFID microchips, which were manufactured by Raytheon Microelectronics España (operating as 'ELCAN Optical Technologies'). The Company expects to use its smaller microchip in its medical diagnostic applications, medical device identification and animal health applications.
The Company is currently in Phase II development of an in vivo glucose-sensing RFID microchip. Phase II development, which includes optimizing the sensing system for its glucose response in the presence of blood and interstitial fluid matrix components, is expected to be completed in mid-2010. Following successful Phase II development, PositiveID intends to integrate the glucose sensor with the electronics interface of the microchip.
Scott R. Silverman, Chairman and CEO of PositiveID, said, 'We believe the manufacture and sale of this first batch of 8-millimeter microchips is another step forward for our Company as we take our microchip beyond identification-only to applications that may help diagnose and potentially treat medical conditions in humans and animals.'" .source
